Results for tag: "High Affinity Nerve Growth Factor Receptor"

The High Affinity Nerve Growth Factor Receptor (HANGR) market is a subset of the Central Nervous System (CNS) Drugs market. HANGR drugs are used to treat neurological disorders such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. These drugs are designed to target the nerve growth factor receptor, which is responsible for the growth and maintenance of neurons in the brain. HANGR drugs are typically administered orally or intravenously, and can be used in combination with other CNS drugs. HANGR drugs are often used in combination with other CNS drugs to improve the efficacy of treatment. This is due to the fact that HANGR drugs can target the nerve growth factor receptor, while other CNS drugs can target other receptors in the brain. This combination of drugs can help to reduce the severity of neurological disorders. Some companies in the HANGR market include AbbVie, AstraZeneca, Biogen, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more